Neurotrophic Effect of a Novel TrkB Agonist on Retinal Ganglion Cells

Abstract

Together, these findings demonstrate the potential for antibody-mediated TrkB agonism as a potential therapeutic approach to enhance RGC survival after optic nerve injury. Further studies are needed to elucidate the mechanistic differences between this TrkB agonist and BDNF.